Should we lower or raise levels of amyloid-β in the brains of Alzheimer patients?
Bruno P. Imbimbo,
Stefania Ippati,
Camillo Imbimbo,
Claudia Balducci
Affiliations
Bruno P. Imbimbo
Department of Research & Development, Chiesi Farmaceutici, Parma, Italy; Corresponding author at: Research & Development Department, Chiesi Farmaceutici, Largo Francesco Belloli 11/a, 43122 Parma, Italy.
Stefania Ippati
San Raffaele Scientific Institute, San Raffaele Hospital, 20132 Milan, Italy
Camillo Imbimbo
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
Claudia Balducci
Department of Neuroscience, Istituto di Ricerche Farmacologiche ''Mario Negri'' IRCCS, Milan, Italy
